Organisation paid for research Program year 2025 Source: CMS Open Payments

Asclepes Research Centers Admin

Neither a doctor nor a teaching hospital

Research payments

$401,474

44 payments

Through program year 2025, Asclepes Research Centers Admin is reported as receiving $401,474 in research payments, across 44 payments.

By program year

2 rows

Year	Kind	Amount	Payments
2025	Research	$155,191	39
2024	Research	$246,283	5

Breakdown

Who paid Research payments · program years 2024–2025

Boehringer Ingelheim International GmbH $226,071 35 payments
Boehringer Ingelheim Pharmaceuticals, Inc. $175,402 9 payments

Studies the money was for Research payments · program years 2024–2025

Phase II DRF study of NR2B modulation in MDD $179,831 2 payments
Phase II dose finding trial in monotherapy for MDD $74,246 12 payments
Connex-2 $61,630 2 payments
A Phase II, 6-week, multicenter, randomized, double blind (patient and investigator) or masked, placebo controlled, dose-finding trial to evaluate the efficacy, tolerability, and safety of different doses of oral BI 1569912 as adjunctive therapy in MD $43,148 26 payments
Connex-X $24,965 1 payment
An open label, single arm, extension trial to examine long-term safety of BI 425809 once daily in patients with schizophrenia who have completed previous BI 425809 Phase III trials.(CONNEX-X) $17,652 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.